Department of Geriatrics, Zhongshan Hospital, Fudan University, 180 Fenglin Road, Shanghai, 200032, China.
BMC Geriatr. 2019 Nov 27;19(1):331. doi: 10.1186/s12877-019-1304-y.
C677T point mutation in methylenetetrahydrofolate reductase (MTHFR) gene have been found to be associated with ischemic stroke in general population, while the results seem inconsistent. We aim to assess the association between variant MTHFR C677T variant and increased risk of ischemic stroke and focus on the elderly population.
We searched PubMed, Embase, Cochrane Library, and Web of Science for eligible studies. Odds ratios (ORs) were calculated with the two-tailed 95% confidence intervals (CIs) by using a random effects model to evaluate any possible association. Among the Chinese and non-Chinese populations, we conducted a subgroup analysis.
The electronic database search yielded 1,358 citations as of December 2017; finally, nine case-control studies involving 3,337 subjects fulfilled our eligibility criteria for inclusion in the study. The pooled results showed that MTHFR C677T variant increased the risk of ischemic stroke (OR = 1.23, 95%CI 1.06-1.43, P = 0.0067 for CT + TT vs. CC; OR = 1.18, 95%CI 1.01-1.38, P = 0.0333 for CT vs. CC; OR = 1.41, 95%CI 1.14-1.75, P = 0.0016 for TT vs. CC; OR = 1.27, 95%CI 1.05-1.54, P = 0.0145 for TT vs. CC + CT; OR = 1.18, 95%CI 1.06-1.31, P = 0.0023 for T-allele vs. C-allele). Further subgroup analyses in the Chinese population indicated that MTHFR C677T variant was associated with a higher risk of ischemic stroke.
Our findings showed that T-allele increases risk for stroke in the pooled sample. This association was statistically significant in the Chinese cohorts and showed a similar trend in the non-Chinese cohorts. (Word count: 237).
亚甲基四氢叶酸还原酶(MTHFR)基因中的 C677T 点突变已被发现与普通人群中的缺血性中风有关,但结果似乎不一致。我们旨在评估变异 MTHFR C677T 变体与缺血性中风风险增加之间的关联,并关注老年人群。
我们在 PubMed、Embase、Cochrane 图书馆和 Web of Science 中搜索了符合条件的研究。使用双尾 95%置信区间(CI)计算比值比(ORs),采用随机效应模型评估任何可能的关联。在中国人和非中国人人群中,我们进行了亚组分析。
截至 2017 年 12 月,电子数据库搜索共产生 1358 条引文;最终,9 项病例对照研究共纳入 3337 名符合条件的受试者。汇总结果显示,MTHFR C677T 变体增加了缺血性中风的风险(OR=1.23,95%CI 1.06-1.43,P=0.0067,CT+TT 与 CC 相比;OR=1.18,95%CI 1.01-1.38,P=0.0333,CT 与 CC 相比;OR=1.41,95%CI 1.14-1.75,P=0.0016,TT 与 CC 相比;OR=1.27,95%CI 1.05-1.54,P=0.0145,TT 与 CC+CT 相比;OR=1.18,95%CI 1.06-1.31,P=0.0023,T 等位基因与 C 等位基因相比)。在中国人群的进一步亚组分析表明,MTHFR C677T 变体与缺血性中风的风险增加相关。
我们的研究结果表明,T 等位基因增加了汇总样本中中风的风险。这种关联在中国人队列中具有统计学意义,在非中国人队列中也表现出相似的趋势。(单词数:237)